Current Locations:Home > PRODUCTS > IBI306

IBI306-Blockbuster Drug for Cardiovascular Disease

Indicated for the treatment of hyperlipidemia; there are over 40 million hyperlipidemia patients in China, the number increases steadily with life improvement and aging population. IBI306 pursues a new treatment approach for hyperlipidemia especially for those with ultrahigh cholesterol. Innovent owns global IP right to the IBI306 molecule.

Copyright © 2011- Innovent Biologics, Inc.
Powered by RuiXi